Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 181 entries
View as:

Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01509209 Org: User:
Start: 05/31/11 End: 04/30/13 Due: 04/30/14

A Drug Interaction Study of Montelukast and Levocetirizine

Phase: N/A Priority: Normal
NCT ID: NCT01491503 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04324905 Org: User:
Start: 04/29/20 End: 10/30/20 Due: 10/30/21

Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations

Phase: N/A Priority: Normal
NCT ID: NCT03372850 Org: User:
Start: 02/15/18 End: 06/15/18 Due: 06/15/19

Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01640535 Org: User:
Start: 06/30/12 End: 02/28/13 Due: 02/28/14

Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin

Phase: N/A Priority: Normal
NCT ID: NCT02239484 Org: User:
Start: 03/31/14 End: 09/30/14 Due: 09/30/15

Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04505436 Org: User:
Start: 07/31/20 End: 11/10/26 Due: 11/10/27

A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT01448330 Org: User:
Start: 07/31/11 End: 09/30/11 Due: 09/30/12

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Phase: N/A Priority: Normal
NCT ID: NCT01197001 Org: User:
Start: 08/31/10 End: 11/30/10 Due: 11/30/11

PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02715401 Org: User:
Start: 10/31/15 End: 11/30/15 Due: 11/30/16

Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung

Phase: N/A Priority: Normal
NCT ID: NCT02485652 Org: User:
Start: 08/31/15 End: 12/08/20 Due: 12/08/21

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT05191563 Org: User:
Start: 07/31/21 End: 09/12/21 Due: 09/12/22

Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573

Phase: N/A Priority: Normal
NCT ID: NCT02405065 Org: User:
Start: 01/12/15 End: 05/16/18 Due: 05/16/19

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Phase: N/A Priority: Normal
NCT ID: NCT01197014 Org: User:
Start: 09/30/10 End: 12/31/10 Due: 12/31/11

Partial Replicated Crossover Clinical Study to Compare Pharmacokinectic Characteristics of Eperisone Hydrochloride and Aceclofenac With HCP1104 Treatment to Those of Co-administration of Eperisone Hydrochloride 50mg Tablet and Aceclofenac 100mg Tablet in Healthy Adult Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01869985 Org: User:
Start: 08/31/13 End: 01/31/14 Due: 01/31/15

Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01830491 Org: User:
Start: 03/31/09 End: 12/31/09 Due: 12/31/10

An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT05422677 Org: User:
Start: 07/15/19 End: 08/24/21 Due: 08/24/22

The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT01828359 Org: User:
Start: 08/31/10 End: 01/31/13 Due: 01/31/14

A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203

Phase: N/A Priority: Normal
NCT ID: NCT05481307 Org: User:
Start: 08/02/22 End: 10/25/22 Due: 10/25/23

Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02529800 Org: User:
Start: 09/30/15 End: 10/31/15 Due: 10/31/16

Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01455571 Org: User:
Start: 11/30/09 End: 01/31/13 Due: 01/31/14

A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04032782 Org: User:
Start: 10/02/18 End: 08/29/19 Due: 08/29/20

Single-dose, 2-way Crossover Open Study to Evaluate the Food Effect on the PK of HCP1201 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01901757 Org: User:
Start: 06/30/13 End: 07/31/13 Due: 07/31/14

Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01872182 Org: User:
Start: 05/31/13 End: 01/31/15 Due: 01/31/16

Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01452451 Org: User:
Start: 12/31/11 End: - Due: -